Wellington Management Group
VRTX icon

Wellington Management Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Wellington Management Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.43B Sell
3,212,589
-609,142
-16% -$284M 0.27% 84
2025
Q4 		$1.73B Sell
3,821,731
-950,311
-20% -$410M 0.3% 71
2025
Q3 		$1.87B Sell
4,772,042
-41,344
-0.9% -$17.3M 0.33% 67
2025
Q2 		$2.14B Sell
4,813,386
-641,362
-12% -$296M 0.39% 61
2025
Q1 		$2.64B Sell
5,454,748
-461,336
-8% -$215M 0.51% 44
2024
Q4 		$2.38B Buy
5,916,084
+1,117,214
+23% +$518M 0.44% 53
2024
Q3 		$2.23B Buy
4,798,870
+704,421
+17% +$338M 0.39% 62
2024
Q2 		$1.92B Sell
4,094,449
-463,784
-10% -$201M 0.34% 66
2024
Q1 		$1.91B Sell
4,558,233
-670,305
-13% -$283M 0.34% 70
2023
Q4 		$2.13B Sell
5,228,538
-1,297,313
-20% -$479M 0.4% 58
2023
Q3 		$2.27B Sell
6,525,851
-1,027,043
-14% -$359M 0.45% 49
2023
Q2 		$2.66B Buy
7,552,894
+35,346
+0.5% +$11.9M 0.5% 43
2023
Q1 		$2.37B Buy
7,517,548
+689,965
+10% +$207M 0.47% 51
2022
Q4 		$1.97B Sell
6,827,583
-1,201,759
-15% -$366M 0.4% 60
2022
Q3 		$2.32B Sell
8,029,342
-206,297
-3% -$59.4M 0.5% 50
2022
Q2 		$2.32B Buy
8,235,639
+181,929
+2% +$48.7M 0.47% 57
2022
Q1 		$2.1B Buy
8,053,710
+1,535,255
+24% +$364M 0.36% 71
2021
Q4 		$1.43B Buy
6,518,455
+427,366
+7% +$83.1M 0.23% 105
2021
Q3 		$1.1B Sell
6,091,089
-2,204,600
-27% -$430M 0.19% 121
2021
Q2 		$1.67B Buy
8,295,689
+209,325
+3% +$43.8M 0.28% 90
2021
Q1 		$1.74B Sell
8,086,364
-1,120,147
-12% -$246M 0.31% 82
2020
Q4 		$2.18B Buy
9,206,511
+3,020,047
+49% +$693M 0.4% 64
2020
Q3 		$1.68B Sell
6,186,464
-275,346
-4% -$76M 0.35% 74
2020
Q2 		$1.88B Sell
6,461,810
-1,149,958
-15% -$312M 0.42% 61
2020
Q1 		$1.81B Buy
7,611,768
+175,609
+2% +$40.3M 0.48% 54
2019
Q4 		$1.63B Sell
7,436,159
-807,388
-10% -$163M 0.34% 66
2019
Q3 		$1.4B Sell
8,243,547
-15,065
-0.2% -$2.67M 0.31% 76
2019
Q2 		$1.51B Sell
8,258,612
-570,173
-6% -$99.7M 0.34% 72
2019
Q1 		$1.62B Buy
8,828,785
+210,383
+2% +$38.9M 0.37% 63
2018
Q4 		$1.43B Sell
8,618,402
-887,386
-9% -$154M 0.36% 68
2018
Q3 		$1.83B Sell
9,505,788
-802,611
-8% -$143M 0.39% 62
2018
Q2 		$1.75B Sell
10,308,399
-767,106
-7% -$119M 0.39% 63
2018
Q1 		$1.81B Sell
11,075,505
-1,308,689
-11% -$214M 0.41% 65
2017
Q4 		$1.86B Sell
12,384,194
-883,152
-7% -$131M 0.41% 63
2017
Q3 		$2.02B Sell
13,267,346
-2,600,854
-16% -$391M 0.46% 54
2017
Q2 		$2.04B Sell
15,868,200
-1,897,733
-11% -$228M 0.48% 52
2017
Q1 		$1.94B Buy
17,765,933
+2,845,775
+19% +$251M 0.47% 51
2016
Q4 		$1.1B Buy
14,920,158
+496,319
+3% +$40.4M 0.28% 93
2016
Q3 		$1.26B Buy
14,423,839
+336,192
+2% +$31.8M 0.32% 77
2016
Q2 		$1.21B Sell
14,087,647
-639,526
-4% -$55.3M 0.31% 75
2016
Q1 		$1.17B Sell
14,727,173
-136,813
-0.9% -$12.4M 0.31% 81
2015
Q4 		$1.87B Buy
14,863,986
+1,405,220
+10% +$170M 0.49% 49
2015
Q3 		$1.4B Sell
13,458,766
-416,455
-3% -$53.5M 0.39% 62
2015
Q2 		$1.71B Sell
13,875,221
-1,483,538
-10% -$187M 0.44% 53
2015
Q1 		$1.81B Sell
15,358,759
-1,835,273
-11% -$220M 0.47% 46
2014
Q4 		$2.04B Sell
17,194,032
-2,664,428
-13% -$300M 0.54% 39
2014
Q3 		$2.23B Buy
19,858,460
+3,397,356
+21% +$323M 0.61% 30
2014
Q2 		$1.56B Buy
16,461,104
+178,644
+1% +$12.5M 0.42% 58
2014
Q1 		$1.15B Sell
16,282,460
-259,526
-2% -$20.6M 0.32% 74
2013
Q4 		$1.23B Buy
16,541,986
+4,439,553
+37% +$309M 0.35% 67
2013
Q3 		$918M Sell
12,102,433
-1,241,549
-9% -$98.8M 0.29% 76
2013
Q2 		$1.07B Buy
+13,343,982
New +$983M 0.35% 66

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wellington Management Group's VRTX Position: Q1 2026 in Review

Wellington Management Group reduced its Vertex Pharmaceuticals (VRTX) stake by 16% in Q1 2026, selling an estimated $284M and leaving 3,212,589 shares worth $1.43B. The position accounts for 0.27% of the portfolio, ranked #84.

Wellington Management Group first reported a position in VRTX in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.66B in Q2 2023. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Wellington Management Group held 3,212,589 shares of Vertex Pharmaceuticals worth $1.43B as of Q1 2026.
  • Wellington Management Group sold 609,142 Vertex Pharmaceuticals shares in Q1 2026, an estimated $284M.
  • Vertex Pharmaceuticals made up 0.27% of Wellington Management Group's portfolio in Q1 2026, its #84 holding.
  • Wellington Management Group first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • Wellington Management Group's Vertex Pharmaceuticals position peaked at $2.66B in Q2 2023.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.